Angiographic changes in iris and iridocorneal angle neovascularization after intravitreal bevacizumab injection

Archives of Ophthalmology

Volumn 128, Issue 12, 2010, Pages 1539-1545

  Ishibashi, Shingo ^a   Tawara, Akihiko ^a   Sohma, Rika ^a   Kubota, Toshiaki ^a   Toh, Norihiko ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; FLUORESCEIN; INDOCYANINE GREEN;

ADULT; AGED; ANTERIOR EYE SEGMENT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; DIABETIC RETINOPATHY; DRUG EFFICACY; FEMALE; GLAUCOMA; HUMAN; IRIDOCORNEAL ANGLE NEOVASCULARIZATION; IRIS BLOOD VESSEL; IRIS DISEASE; MALE; PRIORITY JOURNAL; RETINA ANGIOGRAPHY; RETINA VEIN OCCLUSION; SLIT LAMP; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CAPILLARY PERMEABILITY; CILIARY BODY; COLORING AGENTS; FEMALE; FLUORESCEIN ANGIOGRAPHY; GLAUCOMA, NEOVASCULAR; GONIOSCOPY; HUMANS; INDOCYANINE GREEN; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; IRIS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 78650114110     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2010.282     Document Type: Article

References (24)

1. Wand M. Neovascular glaucoma. In: Ritch R, Shields MB, Krupin T, eds. The Glaucomas. 2nd ed. St Louis, MO: Mosby-Year Book; 1996:1073-1129.
2. Kubota T, Tawara A, Hata Y, Khalil A, Inomata H. Neovascular tissue in the intertrabecular spaces in eyes with neovascular glaucoma. Br J Ophthalmol. 1996; 80(8):750-754. (Pubitemid 26334921)
3. Tolentino MJ, Miller JW, Gragoudas ES, Chatzistefanou K, Ferrara N, Adamis AP. Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate. Arch Ophthalmol. 1996; 114(8):964-970. (Pubitemid 26271462)
4. Tripathi RC, Li J, Tripathi BJ, Chalam KV, Adamis AP. Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. Ophthalmology. 1998;105(2):232-237. (Pubitemid 28090825)
5. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004; 350(23):2335-2342. (Pubitemid 38702844)
6. Gheith ME, Siam GA, de Barros DS, Garg SJ, Moster MR. Role of intravitreal bevacizumab in neovascular glaucoma. J Ocul Pharmacol Ther. 2007;23(5):487-491. (Pubitemid 350202480)
7. Kelkar AS, Kelkar SB, Kelkar JA, Nagpal M, Patil SP. The use of intravitreal bevacizumab in neovascular glaucoma: a case report. Bull Soc Belge Ophtalmol. 2007; (303):43-45.
8. Yazdani S, Hendi K, Pakravan M. Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma. J Glaucoma. 2007;16(5):437-439. (Pubitemid 47263045)
9. Andrijević-Derk B, Vatavuk Z, Bencić G, Novak-Laus K, Mandić Z. Intravitreal bevacizumab for neovascular glaucoma. Acta Clin Croat. 2008;47(3):175-179.
10. Costagliola C, Cipollone U, Rinaldi M, della Corte M, Semeraro F, Romano MR. Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma: a survey on 23 cases throughout 12-month follow-up. Br J Clin Pharmacol. 2008;66 (5):667-673.
11. Kubota T, Aoki R, Harada Y, Tou N, Tawara A. Intravitreal injection of bevacizumab to treat neovascular glaucoma. Jpn J Ophthalmol. 2008;52(5):410-412.
12. Beutel J, Peters S, Lüke M, et al. Bevacizumab as adjuvant for neovascular glaucoma. Acta Ophthalmol (Copenh). 2010;88(1):103-109.
13. Wakabayashi T, Oshima Y, Sakaguchi H, et al. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Ophthalmology. 2008;115(9):1571-1580, 1580.e1-1580.e3. doi:10.1007/s10384-008-0573-3.
14. Chalam KV, Gupta SK, Grover S, Brar VS, Agarwal S. Intracameral Avastin dramatically resolves iris neovascularization and reverses neovascular glaucoma. Eur J Ophthalmol. 2008;18(2):255-262. (Pubitemid 351692186)
15. Cheng JY, Wong DW, Ang CL. Intraocular Avastin (bevacizumab) for neovascularisation of the iris and neovascular glaucoma. Ann Acad Med Singapore. 2008; 37(1):72-74.
16. Krohne TU, Eter N, Holz FG, Meyer CH. Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans. Am J Ophthalmol. 2008; 146(4):508-512.
17. Maruyama Y, Kishi S, Kamei Y, Shimizu R, Kimura Y. Infrared angiography of the anterior ocular segment. Surv Ophthalmol. 1995;39(suppl 1):S40-S48.
18. Kubota T, Aoki R, Harada Y, et al. Trabecular meshwork in neovascular glaucoma eyes after the intravitreal injection of bevacizumab. Br J Ophthalmol. 2009; 93(4):557-558.
19. Peters S, Heiduschka P, Julien S, et al; Tübingen Bevacizumab Study Group. Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab. Am J Ophthalmol. 2007;143(6):995-1002.
20. Peters S, Julien S, Heiduschka P, et al. Antipermeability and antiproliferative effects of standard and frozen bevacizumab on choroidal endothelial cells. Br J Ophthalmol. 2007;91(6):827-831. (Pubitemid 46846661)
21. Davidorf FH, Mouser JG, Derick RJ. Rapid improvement of rubeosis iridis from a single bevacizumab (Avastin) injection. Retina. 2006;26(3):354-356. (Pubitemid 44318196)
22. Oshima Y, Sakaguchi H, Gomi F, Tano Y. Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy. Am J Ophthalmol. 2006;142(1):155-158.
23. Batioǧlu F, Astam N, Ozmert E. Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma. Int Ophthalmol. 2008; 28(1):59-61. (Pubitemid 351308686)
24. Inomata H, Ishibashi T, Murata T, Iwasaki M. Diabetes and eye: morphological aspects of ocular complications of diabetes [in Japanese]. Saibou. 1993;25: 180-184.